|
|
DEVELOPMENT OF EP2 RECEPTOR ANTAGONISTS FOR SUPPRESSION OF ALZHEIMER'S NEUROPATHOLOGY |
| 5U01AG052460-02 |
GANESH, THOTA |
NIA |
2017 |
|
|
2016-2018 DRUG DISCOVERY FOR NEURODEGENERATION CONFERENCES |
| 5U13AG052268-03 |
FILLIT, HOWARD M. |
NIA |
2017 |
|
|
ALZHEIMER'S DISEASE COOPERATIVE STUDY |
| 5U19AG010483-26 |
FELDMAN, HOWARD |
NIA |
2017 |
|
|
RESVERATROL AND EXERCISE TO TREAT FUNCTIONAL LIMITATIONS IN LATE LIFE |
| 7R21AG049974-03 |
BUFORD, THOMAS W |
NIA |
2017 |
|
|
BRAIN ATROPHY, COGNITIVE IMPAIRMENT AND ALZHEIMER'S IN A LOW CVD-RISK POPULATION |
| 7RF1AG054442-02 |
KAPLAN, HILLARD S |
NIA |
2017 |
|
|
INTERACTIVE TELEHEALTH AND AUTO-BIOFEEDBACK SENSOR SYSTEM FOR INDIVIDUALS WHO USE A WHEELCHAIR |
| 9R44AG059275-03A1 |
GWIN, JOSEPH T |
NIA |
2017 |
